These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33021720)

  • 1. Investigation of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-chromen-2-one as a promising coumarin compound for the development of a new and orally effective antileishmanial agent.
    de Figueiredo Peloso E; Merli RJ; Espuri PF; Nunes JB; Colombo FA; Sierra EJT; de Paulo DC; Dos Santos MH; Carvalho DT; Marques MJ
    Mol Biol Rep; 2020 Nov; 47(11):8465-8474. PubMed ID: 33021720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route.
    Gontijo VS; Colombo FA; Ferreira Espuri P; Freitas PG; Nunes JB; Alves LB; Veloso MP; Alves RB; Freitas RP; Marques MJ
    Exp Parasitol; 2021; 226-227():108123. PubMed ID: 34144040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis.
    de Jesus JA; Laurenti MD; Antonangelo L; Faria CS; Lago JHG; Passero LFD
    J Immunol Res; 2021; 2021():6671287. PubMed ID: 33681389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites.
    Antinarelli LMR; Meinel RS; Coelho EAF; da Silva AD; Coimbra ES
    J Pharm Pharmacol; 2019 Dec; 71(12):1854-1863. PubMed ID: 31595530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity and in vivo efficacy of fexinidazole against New World Leishmania species.
    de Morais-Teixeira E; Rabello A; Aguiar MMG
    J Antimicrob Chemother; 2019 Aug; 74(8):2318-2325. PubMed ID: 31049550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis.
    Brenzan MA; Nakamura CV; Prado Dias Filho B; Ueda-Nakamura T; Young MC; Aparício Garcia Cortez D
    Parasitol Res; 2007 Aug; 101(3):715-22. PubMed ID: 17483964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum.
    Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO
    Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial compounds from Connarus suberosus: Metabolomics, isolation and mechanism of action.
    Morais LS; Dusi RG; Demarque DP; Silva RL; Albernaz LC; Báo SN; Merten C; Antinarelli LMR; Coimbra ES; Espindola LS
    PLoS One; 2020; 15(11):e0241855. PubMed ID: 33156835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl gallate: Selective antileishmanial activity correlates with host-cell directed effects.
    Noleto Dias C; Nunes TAL; Sousa JMS; Costa LH; Rodrigues RRL; Araújo AJ; Marinho Filho JDB; da Silva MV; Oliveira MR; Carvalho FAA; Rodrigues KADF
    Chem Biol Interact; 2020 Apr; 320():109026. PubMed ID: 32112863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative and ultrastructural effects of phenethylamine derivatives on promastigotes and amastigotes of Leishmania (Leishmania) infantum chagasi.
    Brasil PF; de Freitas JA; Barreto ALS; Adade CM; Reis de Sá LF; Constantino-Teles P; Toledo FT; de Sousa BA; Gonçalves AC; Romanos MTV; Comasseto JV; Dos Santos AA; Tessis AC; Souto-Padrón T; Soares RMA; Ferreira-Pereira A
    Parasitol Int; 2017 Apr; 66(2):47-55. PubMed ID: 27888011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of imidazole compounds on Leishmania (L.) infantum chagasi: reactive oxygen species induced by econazole.
    Mesquita JT; da Costa-Silva TA; Borborema SE; Tempone AG
    Mol Cell Biochem; 2014 Apr; 389(1-2):293-300. PubMed ID: 24374794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites.
    Varela-M RE; Villa-Pulgarin JA; Yepes E; Müller I; Modolell M; Muñoz DL; Robledo SM; Muskus CE; López-Abán J; Muro A; Vélez ID; Mollinedo F
    PLoS Negl Trop Dis; 2012; 6(4):e1612. PubMed ID: 22506086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.